Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells

Journal of Endocrinology

Volumn 178, Issue 2, 2003, Pages 319-329

  Takahashi, K ^a,b   Ohmichi, Masa ^a,b   Yoshida, M ^a   Hisamoto, K ^b   Mabuchi, S ^b   Arimoto Ishida, E ^b   Mori, A ^a   Tsutsumi, S ^a   Tasaka, K ^b   Murata, Y ^b   Kurachi, H ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL]BENZO[B]THIOPHENE; COMPLEMENTARY DNA; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; PLATELET DERIVED GROWTH FACTOR; PROTEIN P27; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NONHUMAN; PATHOPHYSIOLOGY; PHASE TRANSITION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; AORTA; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; CELLS, CULTURED; CYCLIN D1; DEPRESSION, CHEMICAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FLOW CYTOMETRY; G1 PHASE; HUMANS; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; RALOXIFENE; RATS; RECEPTORS, ESTROGEN; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TRANSFECTION;

EID: 0042353842     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1780319     Document Type: Article

References (62)

1. Abrieu A, Lorca T, Labbe JC, Morin N, Keyse S & Doree M 1996 MAP kinase does not inactivate, but rather prevents the cyclin degradation pathway from being turned on in Xenopus egg extracts. Journal of Cell Science 109 239-246.
2. Belchetz PE 1994 Hormonal treatment of postmenopausal women. New England Journal of Medicine 330 1062-1071.
3. Blobel GA & Orkin SH 1996 Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Molecular and Cellular Biology 16 1687-1694.
4. Braun-Dullaeus RC, Mann MJ & Dzau VJ 1998 Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation 98 82-89.
5. Calcagno D, Bei M, Koss SA, Klein A & Foegh ML 1992 Effects of estrogen on vein grafts. Journal of Cardiovascular Surgery 33 579-584.
6. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV & Auricchio F 2001 PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO Journal 20 6050-6059.
7. Claesson-Welsh L 1994 Platelet-derived growth factor receptor signals. Journal of Biological Chemistry 269 32023-32026.
8. Chen RH, Sarnecki C & Blenis J 1992 Nuclear localization and regulation of crk- and rsk-encoded protein kinases. Molecular and Cellular Biology 12 915-927.
9. Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A & Jordan VC 1999 The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. Journal of the American Medical Association 282 2189-2197.
10. Dai-Do D, Espinosa E, Liu G, Rabelink TJ, Julmy F, Yang Z, Mahler F & Lusscher TF 1996 17β-Estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males. Cardiovascular Research 32 980-985.
11. Dubey RK, Gillespie DG, Imthurn B, Rosselli M, Jackson EK & Keller PJ 1999 Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension 33 177-182.
12. Dubey RK, Jackson EK, Gillespie DG, Zacharia LC, Imthurn B & Keller PJ 2000 Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arteriosclerosis, Thrombosis, and Vascular Biology 20 964-972.
13. Forrester JS, Fishbein M, Helfant R & Fagin J 1991 A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. Journal of the American College of Cardiology 17 758-769.
14. Garg UC & Hassid A 1989 Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation 83 1774-1777.
15. Gilligan DM, Badar DM, Panza JA, Quyyumi AA & Cannon RO 3rd 1994 Acute vascular effects of estrogen in postmenopausal women. Circulation 90 786-791.
16. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, Leslie CC & Krebs EG 1996 Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. Journal of Biological Chemistry 271 505-511.
17. Hanke H 1996 Proliferative response of smooth muscle cells after experimental balloon angioplasty. Circulation 93 202.
18. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC & Bender JR 2000 Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circulation Research 87 677-682.
19. Hisamoto K, 0hmichi M, Kanda K, Adachi K, Nishio Y, Hayakawa J, Mabuchi S, Takahashi K, Tasaka K, Miyamoto Y, Taniguchi N & Murata Y 2001a Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal-regulated protein kinase in vascular endothelial cells. Journal of Biological Chemistry 276 47642-47649.
20. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N & Murata Y 2001b Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. Journal of Biological Chemistry 276 3459-3467.
21. Hodges YK, Tung L, Yan XD, Graham JD, Horwitz KB & Horwitz LD 2000 Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 101 1792-1798.
22. Hwang KC, Lee KH & Jang Y 2002 Inhibition of MEK1,2/ERK mitogenic pathway by estrogen with antiproliferative properties in rat aortic smooth muscle cells. Journal of Steroid Biochemistry and Molecular Biology 80 85-90.
23. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O'Donnell TF Jr, Korach KS & Mendelsohn ME 1997 Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nature Medicine 3 545-548.
24. Jiang CW, Sarrel PM, Lindsay DC, Poole-Wilson PA & Collins P 1991 Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. British Journal of Pharmacology 104 1033-1037.
25. 1 →S transition in human coronary smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 20 1216-1224.
26. Kolodgie FD, Jacob A, Wilson PS, Carlson GC, Farb A, Verma A & Virmani R 1996 Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. American Journal of Pathology 48 969-976.
27. Kos M, Denger S, Reid G, Korach KS & Gannon F 2002 Down but not out? A novel protein isoform of the estrogen receptor alpha is expressed in the estrogen receptor alpha knockout mouse. Journal of Molecular Endocrinology 3 281-286.
28. Kourembanas S, Morita T, Christou H, Liu Y, Koike H, Brodsky D, Arthur V & Mitsial SA 1998 Hypoxic responses of vascular cells. Chest 114 25S-28S.
29. La Thangue NB 1996 E2F and the molecular mechanisms of early cell-cycle control. Biochemical Society Transactions 24 54-59.
30. Lavoie JN, L'Allemain G, Brunet A, Muller R & Pouyssegur J 1996 Cyclin D1 expression is regulated positively by the p42/p44 MAPK and negatively by the p38/HOGMAPK pathway. Journal of Biological Chemistry 271 20608-20616.
31. kip1. Circulation 102 2124-2130.
32. Mendelsohn ME & Karas RH 1999 The protective effects of estrogen on the cardiovascular system. New England Journal of Medicine 340 1801-1811.
33. Minamino T & Kourembanas S 2001 Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circulation Research 89 237-243.
34. Moncada S & Higgs A 1993 The L-arginine-nitric oxide pathway. New England Journal of Medicine 329 2002-2012.
35. Nevins JR 1992 E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258 424-429.
36. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P & Mendelsohn ME 2002 Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circulation Research 90 1087-1092.
37. Razandi M, Pedram A & Levin ER 2000 Estrogen signals to the preservation of endothelial cell form and function. Journal of Biological Chemistry 275 38540-38546.
38. Reil TD, Kashyap VS, Sarkar R, Freishlag J & Gelabert HA 2000 Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation. Journal of Surgical Research 92 108-113.
39. Rosano GM, Sarrel PM, Poole-Wilson PA & Collins P 1993 Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342 133-136.
40. Ross R 1986 The pathogenesis of atherosclerosis - an update. New England Journal of Medicine 314 488-500.
41. Ross R 1995 Cell biology of atherosclerosis. Annual Review of Physiology 57 791-804.
42. 2+ channels in smooth muscle cells. FASEB Journal 12 613-619.
43. Schwartz SM, deBlois D & O'Brien ER 1995 The intima: soil for atherosclerosis and restenosis. Circulation Research 77 445-465.
44. Seth A, Gonzalez FA, Gupta S, Raden DL & Davis RJ 1992 Signal transduction within the nucleus by mitogen-activated protein kinase. Journal of Biological Chemistry 267 24796-24804.
45. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW & Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 538-541.
46. Somjen D, Kohen F, Jaffe A, Amir-Zaltsman A, Knoll E & Stern N 1998 Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension 32 39-45.
47. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE & Hennekens CH 1991 Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses health study. New England Journal of Medicine 325 756-762.
48. Stuart WD, Maeda S, Khera P, Fagin JA & Clemens TL 2000 Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells. American Journal of Physiology: Endocrinology and Metabolism 279 E60-E67.
49. Sullivan TR Jr, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell TF Jr & Mendelsohn ME 1995 Estrogen inhibits the response-to-injury in a mouse carotid artery model. Journal of Clinical Investigation 96 2482-2488.
50. Suzuki A, Mizuno K, Ino Y, Okada M, Kikkawa F, Mizutani S & Tomoda Y 1996 Effect of 17β-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro. Cardiovascular Research 32 516-523.
51. Takeda-Matsubara Y, Nakagami H, Iwai M, Cui TX, Shiuchi T, Akishita M, Nahmias C, Ito M & Horiuchi M 2002 Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II. Hypertension 39 41-45.
52. Treon SP, Teoh G, Urashima M, Ogata A, Chauhan D, Webb IJ & Anderson KC 1998 Anti-estrogens induce apoptosis of multiple myeloma cells. Blood 92 1749-1757.
53. Wakino S, Kintscher U, Kim S, Jackson S, Yin F, Nagpal S, Chandraratna RA, Hsueh WA & Law RE 2001 Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators. Arteriosclerosis, Thrombosis, and Vascular Biology 21 746-751.
54. Wang LH, Yang XY, Mihalic K, Xiao W, Li D & Farrar WL 2001 Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3. Journal of Biological Chemistry 276 31839-31844.
55. Weinberg PA 1995 The retinoblastoma protein and cell cycle control. Cell 81 323-330.
56. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG & Moncada S 1994 Induction of calcium-dependent nitric oxide synthases by sex hormones. PNAS 91 5212-5216.
57. WAFI/CIPI is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. Journal of Biological Chemistry 275 10285-10290.
58. Williams JK, Adams MR & Klopfenstein HS 1990 Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81 1680-1687.
59. Williams JK, Adams MR, Herrington DM & Clarkson TB 1992 Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. Journal of the American College of Cardiology 20 452-457.
60. Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288 321-333.
61. Yang Z, Kozaki T, von der Loo B, Viswambharan H, Lachat M & Turina MI 2000 HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins. Journal of the American College of Cardiology 36 1691-1697.
62. Yoon BK, Oh WJ, Kessel B, Roh CR, Choi D, Lee JH & Kim DK 2001 17 Beta-estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism. Menopause 8 58-64.